Leukotriene production is increased in abdominal obesity.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
      Leukotrienes/*biosynthesis ; Obesity, Abdominal/*metabolism; Adolescent ; Adult ; Aged ; Aged, 80 and over ; C-Reactive Protein/metabolism ; Cohort Studies ; Female ; Humans ; Insulin Resistance ; Leukotrienes/urine ; Male ; Middle Aged ; Multivariate Analysis ; Obesity, Abdominal/complications ; Obesity, Abdominal/urine ; Sleep Apnea Syndromes/complications ; Sleep Apnea Syndromes/metabolism ; Young Adult
    • Abstract:
      Obesity is a major risk factor for insulin resistance and type-2 diabetes. A chronic low grade inflammatory state has been described during obesity and associated with insulin resistance pathogenesis. Results from animal studies are in favor of a role of the leukotriene (LT) pathway in obesity induced-insulin resistance. However, there is a paucity of data regarding this association in human obesity. Therefore, the aim of this study was to investigate whether LT production was associated with insulin resistance and other metabolic parameters in a cohort of obese subjects. Forty-six (70% females) obese subjects (BMI≧30 kg/m2) without known diabetes and without inflammatory disease (CRP<10 mg/l) were included. Median age was 44 years (16-80) with a median BMI of 36.8 kg/m2 (30-51). Insulin resistance was evaluated by HOMA-IR index and glucose tolerance test. Urinary LTE4 (U-LTE4) concentration was measured by enzyme immune assay. Screening for obstructive sleep apnea was performed. There was a positive association of U-LTE4 with waist to hip ratio, systolic blood pressure and HOMA-IR in univariate analysis. Further, waist to hip ratio remained the only parameter significantly correlated with U-LTE4, in adjusted multivariate analysis. Taken together, these results confirm the previously established notion of chronic low grade inflammation in obesity and further suggests a role for the LT pathway in obesity-associated development of insulin resistance in humans.
    • Comments:
      Erratum in: PLoS One. 2015;10(1):e0117861. (PMID: 25615625)
    • References:
      Prostaglandins Other Lipid Mediat. 2005 Dec;78(1-4):291-9. (PMID: 16303623)
      Nat Rev Immunol. 2011 Feb;11(2):85-97. (PMID: 21252989)
      Allergy. 2008 May;63(5):570-4. (PMID: 18394131)
      J Immunol. 2010 Apr 1;184(7):3978-87. (PMID: 20207999)
      Diabetes. 2012 Sep;61(9):2311-9. (PMID: 22688342)
      Diabet Med. 1998 Jul;15(7):539-53. (PMID: 9686693)
      J Allergy Clin Immunol. 2012 Mar;129(3):702-707.e2. (PMID: 22244598)
      Nat Med. 2012 Mar;18(3):363-74. (PMID: 22395709)
      J Allergy Clin Immunol. 2009 Aug;124(2):364-70, 370.e1-2. (PMID: 19596146)
      Eur J Clin Invest. 2011 Jan;41(1):30-8. (PMID: 20825465)
      Obes Rev. 2012 Dec;13 Suppl 2:30-9. (PMID: 23107257)
      J Lipid Res. 2012 Sep;53(9):1944-51. (PMID: 22761257)
      J Intern Med. 2007 Oct;262(4):408-14. (PMID: 17875176)
      Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E175-87. (PMID: 20978234)
      Adipocyte. 2013 Oct 1;2(4):262-5. (PMID: 24052903)
      Circulation. 2002 Dec 17;106(25):3143-421. (PMID: 12485966)
      Am J Respir Crit Care Med. 2008 Sep 1;178(5):469-75. (PMID: 18565954)
      Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):347-53. (PMID: 21587068)
      J Allergy Clin Immunol. 2008 May;121(5):1087-93; quiz 1094-5. (PMID: 18405959)
      Pharmacol Rev. 2011 Sep;63(3):539-84. (PMID: 21771892)
      Clin Exp Allergy. 2007 Apr;37(4):476-84. (PMID: 17430342)
      Circ Res. 2007 Apr 13;100(7):946-9. (PMID: 17379835)
      Science. 2013 Jan 11;339(6116):172-7. (PMID: 23307735)
      Eur Respir J. 2006 Mar;27(3):495-503. (PMID: 16507848)
      Int J Obes (Lond). 2006 Mar;30(3):447-52. (PMID: 16261187)
      Sleep. 2011 Aug;34(8):1135-041. (PMID: 21804676)
      Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1771-6. (PMID: 22815343)
      Circulation. 2003 Jan 28;107(3):391-7. (PMID: 12551861)
      Chest. 2008 Aug;134(2):317-23. (PMID: 18641097)
      Diabetologia. 2010 Sep;53(9):2068-70. (PMID: 20535444)
      J Immunol. 2011 Aug 15;187(4):1942-9. (PMID: 21742977)
      Curr Hypertens Rep. 2010 Apr;12(2):99-104. (PMID: 20424938)
      Cardiovasc Diabetol. 2013;12:41. (PMID: 23452437)
      Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):547-66. (PMID: 16311216)
      Pharmacol Ther. 2006 Apr;110(1):83-102. (PMID: 16297979)
      Diabetologia. 1985 Jul;28(7):412-9. (PMID: 3899825)
      Dis Markers. 2013;35(5):475-80. (PMID: 24198444)
    • Accession Number:
      0 (Leukotrienes)
      9007-41-4 (C-Reactive Protein)
    • Publication Date:
      Date Created: 20141202 Date Completed: 20160222 Latest Revision: 20181113
    • Publication Date:
      20231215
    • Accession Number:
      PMC4249847
    • Accession Number:
      10.1371/journal.pone.0104593
    • Accession Number:
      25437865